Allergy Therapeutics PLC AGY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 2.85
- Day Range
- GBX 2.80–2.90
- 52-Week Range
- GBX 0.37–3.20
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 13.58 Bil
- Volume/Avg
- 515,871 / 751,149
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.91
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 612
Valuation
|
Metric
|
AGY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.22 |
Price/Sales | 0.91 |
Price/Cash Flow | — |
Price/Earnings
AGY
Financial Strength
|
Metric
|
AGY
|
|---|---|
Quick Ratio | 0.93 |
Current Ratio | 1.40 |
Interest Coverage | −8.33 |
Quick Ratio
AGY
Profitability
|
Metric
|
AGY
|
|---|---|
Return on Assets (Normalized) | −67.53% |
Return on Equity (Normalized) | −233.81% |
Return on Invested Capital (Normalized) | −105.00% |
Return on Assets
AGY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Tvwbsmnsr | Lpgfy | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Cjvpnmxb | Mvtz | $68.9 Bil | |
HLN
| Haleon PLC ADR | Knkwbvdyq | Prm | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Rywzmvjw | Hbzk | $14.8 Bil | |
VTRS
| Viatris Inc | Zhfwmqzk | Kljnv | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ksbyhwmy | Kwqb | $11.9 Bil | |
CTLT
| Catalent Inc | Vvddggqv | Hykdddh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Jnkrkxntm | Qlld | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Hvmfckg | Zrc | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Gdyvkwc | Hfstct | $3.5 Bil |